India’s fintech revolution has matured into a trillion-dollar opportunity by 2030, reshaping how hundreds of millions manage, borrow, invest, and insure their finances.
Mankind Pharma, Laurus Labs, and PAYTM share prices are currently in bullish breakout on technical charts. Mankind Pharma was trading 4.2 percent higher at the time of publication of this report.
Motilal Oswal Financial Services has issued a Neutral call on One 97 Communications (Paytm), with a revised target price of Rs 1,000, reflecting an 8% upside from current levels.